New Key Statistics Module, Z-Score and F-Score
TSXV:NPTH Key Ratios
Market Cap C$ M | 10.13 |
Enterprise Value C$ M | 19.55 |
P/E(ttm) | 9,999.00 |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.43 |
Price/Sales | 0.14 |
Price/Free Cash Flow | 3.54 |
Price/Owner Earnings | 3.86 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 66.00 |
EPS (TTM) C$ | -- |
Beneish M-Score | -3.08 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 19.88 |
EV-to-EBITDA | 5.45 |
PEG | -- |
Shares Outstanding M | 56.29 |
Net Margin (%) | -0.16 |
Operating Margin % | 0.67 |
Pre-tax Margin (%) | 0.08 |
Quick Ratio | 1.16 |
Current Ratio | 1.16 |
ROA % (ttm) | -0.25 |
ROE % (ttm) | -0.49 |
ROIC % (ttm) | -4.33 |
Dividend Yield % | -- |
Altman Z-Score | 1.12 |
TSXV:NPTH Number of Guru Trades
TSXV:NPTH Volume of Guru Trades
Gurus Latest Trades with TSXV:NPTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:NPTH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NeuPath Health Inc Insider Transactions
No Available Data